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Abstract
Feeding can be inhibited by multiple cues, including those associated with satiety, sickness or
unpalatable food. How such anorexigenic signals inhibit feeding at the neural circuit level is
incompletely understood. While some inhibitory circuits have been identified, it is not yet clear
whether distinct anorexigenic influences are processed in a convergent or parallel manner. The
amygdala central nucleus (CEA) has been implicated in feeding control, but its role is
controversial. The lateral subdivision of CEA (CEl) contains a subpopulation of GABAergic
neurons, marked by protein kinase C-δ. Here we show that CEl PKC-δ+ neurons in mice are
activated by diverse anorexigenic signals in vivo, required for the inhibition of feeding by such
signals, and strongly suppress food intake when activated. They receive pre-synaptic inputs from
anatomically distributed neurons activated by different anorexigenic agents. These data suggest
that CEl PKC-δ+ neurons constitute an important node that mediates the influence of multiple
anorexigenic signals.
Introduction
Feeding is a goal-directed behavior that is essential for the survival of all metazoan
organisms1. Elucidating the control of feeding behavior requires an understanding of both
the positive and negative regulation of this activity. Although the positive regulation of
feeding in mammals is increasingly well-understood1-4, the negative regulation of food
intake is comparatively under-studied5,6. Food intake can be attenuated by multiple signals,
including those associated with satiety, sickness and unpalatable tastants. How these diverse
anorexigenic signals inhibit feeding at the neural circuit level is not clear. In particular, it is
not known whether different anorexigenic signals act through parallel pathways, or whether
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they are integrated in a convergent manner by a central node at a relatively early stage in
processing, and if so where that node is located.
The central nucleus of the amygdala (CEA)has long been suggested to play a role in
regulating feeding3,7-9, but the nature of this role is uncertain. A number of
neuromodulators, including those regulating the melanocortin system or opioid signaling,
can affect food intake when infused into the CEA10-14. However lesion studies have
generated conflicting or negative results, reporting small increases15,16, decreases17, or no
change18,19 in food intake. The CEA is a heterogeneous nucleus that comprises several
different subdivisions, each containing multiple neuronal subclasses20-22. Thus one potential
explanation for the conflicting data on the role of CEA in feeding is that different
manipulations may affect different cell types, in an undefined manner.
Here we have investigated the role in feeding control of a genetically identified
subpopulation of CEA neurons, which express protein kinase C-delta (PKC-δ)20 and are
located in the lateral subdivision of CEA (CEl). We find that this subpopulation is activated
by multiple anorexigenic signals in vivo. Functional manipulation of these neurons indicates
that they are required for the inhibition of feeding by several anorexigenic signals, and that
their optogenetic activation robustly and acutely inhibits food intake. Monosynaptic
retrograde tracing experiments indicate that upstream neurons activated by different
anorexigenic signals and located in multiple brain regions converge onto CEl PKC-δ+
neurons, rather than onto a common input to these neurons. These data suggest that CEl
PKC-δ+ neurons mediate the inhibitory influence on feeding of multiple anorexigenic
signals, implying that they constitute an important node in the integration and processing of
such signals.
Results
CEl PKC-δ+ neurons are activated by diverse anorexigenic signals
PKC-δ labels ∼50% of CEl GABAergic neurons20. To investigate the involvement of CEl
PKC-δ+ neurons in the regulation of feeding, we first monitored c-Fos expression after
intraperitoneal injection of several known anorexigenic signals: cholecystokinin (CCK)
which mimics satiety23, lithium chloride (LiCl) which induces nausea and visceral
malaise24, and lipopolysaccharide (LPS) which triggers a wide range of inflammatory and
sickness responses25,26. Double immunostaining for c-Fos and PKC-δ indicated that these
anorexigenic agents induced significant c-Fos expression in CEl PKC-δ+ neurons, and more
importantly that PKC-δ marks a sizeable fraction of c-Fos+ neurons activated by CCK or
LiCl (but not LPS; Fig. 1a, d-e, and Supplementary Fig. 1a). Notably, almost 80% of Fos+
neurons activated by CCK in CEl were PKC-δ+ (Supplementary Fig. 1a).
Because CCK has been suggested to be a mediator of satiety23, we investigated whether CEl
PKC-δ+ neurons become activated during satiation. Indeed, we observed a significant c-Fos
induction in CEl PKC-δ+ neurons 3 hr after ad libitum feeding by mice that had been food-
deprived for24 h (Fig. 1b, f-g, and Supplementary Fig. 1b). Finally, we examined activation
by bitter tastants, which also reduce food intake. We observed c-Fos induction in CEl PKC-
δ+ neurons after oral infusion of quinine solution but not water or sucrose (Fig. 1c, h-i, and
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Supplementary Fig. 1c). These data suggest that CEl PKC-δ+ neurons are activated by
diverse anorexigenic signals including those associated with satiety, nausea and
unpalatability.
PKC-δ+ neuronal activity is required for anorexigenic influences
We next investigated whether the activity of CEl PKC-δ+ neurons is required for feeding
inhibition by the anorexigenic agents that activated these cells. To do this, we
pharmacogenetically inhibited CEl PKC-δ+ neurons using an inhibitory DREADD GPCR
(hM4Di) that is activated by the pharmacologically inert ligand CNO27. Selective expression
of hM4Di in these neurons was achieved using a transgenic mouse line in which Cre
recombinase is specifically expressed in PKC-δ+ neurons20. Because PKC-δ is expressed in
multiple brain regions20, we restricted expression of hM4Di to CEl via intracranial
stereotaxic injection of a Cre-dependent adeno-associated virus (AAV) encoding hM4Di
(AAV8-hSyn-DIO-hM4Di-mCherry)28. Electrophysiological analysis in acute amygdala
slices20 confirmed that CNO inhibited spiking in hM4Di-mCherry-expressing PKC-δ+
neurons (Fig. 2a).
Anorexigenic agents such as CCK, LiCl and LPS strongly inhibit feeding in food-deprived
mice. Because these agents activate PCKC-δ+ neurons, we tested whether pharmacogenetic
inhibition of PKC-δ+ neuronal activity could overcome the effect of these anorexigenic
agents. c-Fos induction by CCK, LiCl and LPS in PKC-δ+ neurons expressing hM4Di was
significantly reduced by CNO co-administration (Supplementary Fig. 2a, b), indicating that
pharmacogenetic inhibition of these neurons was effective in vivo. Importantly, inhibition of
these neurons rescued the effect of CCK to inhibit feeding in food-deprived animals (Fig.
2b, CCK, light-blue vs. dark-blue bars). Food intake (measured 20 min after drug
administration) was restored to a level statistically indistinguishable from control mice that
did not receive CCK (Fig. 2b, saline vs. CCK, dark-blue bars). Administration of saline
rather than CNO to CCK-treated hM4Di-expressing mice failed to rescue feeding (Fig. 2b,
CCK, light-blue bar). Similarly, CNO failed to rescue feeding in CCK-treated mice
expressing humanized Renilla GFP (hrGFP)29, rather than hM4Di, in CEl PKC-δ+ neurons
(Fig. 2b, CCK, black bar). Pharmacogenetic inhibition of CEl PKC-δ+ neurons also
overcame the anorexigenic effect of LiCl (Fig. 2b, LiCl), while feeding inhibition induced
by LPS was unaffected (Fig. 2b, LPS). Strikingly, this “rank-order potency” of rescue from
anorexia (CCK>LiCl>LPS) mirrored the rank order potency of c-Fos induction in CEl PKC-
δ+ neurons (Fig. 1d-e). Pharmacogenetic silencing of CEl PKC-δ+ neurons did not increase
food intake in 24 h food-deprived animals in the absence of anorexigenic drugs (Fig. 2b,
saline, light-blue vs. dark-blue bars), indicating a true epistatic interaction with the drugs
rather than an independent compensating effect to promote feeding.
To extend these observations, we asked whether hM4Di/CNO-mediated silencing of CEl
PKC-δ+ neurons could overcome the suppression of feeding by bitter tastants in food-
deprived mice. Indeed, addition of quinine to food pellets significantly reduced food intake,
and this reduction was reversed by CNO administration to mice expressing hM4Di in PKC-
δ+ neurons (Fig. 2c). Surprisingly, however, pharmacogenetic silencing of PKC-δ+ neurons
did not reduce sensitivity to bitter tastants as determined using quantitative lickometer
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assays (Supplementary Fig. 3a-b). This result suggests that these neurons gate the intake of
potentially toxic food resources, rather than controlling gustatory sensitivity or
discrimination. Taken together, these data suggest that CEl PKC-δ+ neurons mediate feeding
inhibition by many (although not all) anorexigenic agents.
Silencing CEl PKC-δ+ neurons increases feeding in satiated mice
Because the satiety signal CCK, as well as re-feeding of food-deprived mice to satiety,
induced c-Fos in CEl PKC-δ+ neurons (Fig. 1a-b, d-g), we asked whether silencing CEl
PKC-δ+ neurons would increase food intake in fed mice. Indeed, CNO injection caused a
robust (∼2-fold) and significant increase in food intake in fed mice expressing hM4Di in
CEl PKC-δ+ neurons (Fig. 2d). To confirm this effect using an independent method, we
silenced CEl PKC-δ+ neurons using eNpHR3.030. Brain slice recordings confirmed that CEl
PKC-δ+ neurons expressing eNpHR3.0 can be strongly silenced by 593 nm laser light (Fig.
3a-b, and Methods). For in vivo behavioral testing, light was delivered through optic ferrule
fibers implanted just above the injection sites (Fig. 3c). Consistent with our
pharmacogenetic results, bilateral optogenetic silencing of PKC-δ+ neurons also
significantly increased food intake in fed mice (Fig. 3d). These data suggest that the activity
of CEl PKC-δ+ neurons is required to limit food intake in sated mice.
The time-resolved manipulations afforded by optogenetic silencing of PKC-δ+ neurons
allowed us to examine the role of these neurons during re-feeding of food-deprived mice.
eNpHR3.0-mediated silencing significantly increased the number of feeding bouts, but not
the average bout duration, and caused a trend to a decreased latency to feed (Fig. 3e-h).
Cumulative bout analysis (Fig. 3i) indicated that mice with silenced PKC-δ+ neurons took
longer to reach plateau than controls (T0.5(eNpHR) = 8.2 min, T0.5(hrGFP) = 4.2 min),
suggesting that they achieved satiety more slowly. Together, these data indicate that the
normal kinetics of feeding reduction as animals reach satiety requires PKC-δ+ neuronal
activity.
Activation of CEl PKC-δ+ neurons inhibits feeding
The foregoing loss-of-function data raised the question of whether artificial activation of
CEl PKC-δ+ neurons would suffice to inhibit food intake. To test this, we expressed ChR2
in CEl PKC-δ+ neurons using a Cre-dependent AAV (AAV2-EF1α-DIO-ChR2-EYFP)31.
Whole-cell patch clamp recordings in CEA brain slices from virus-injected PKC-δ-Cre mice
confirmed that 473 nm light pulses triggered robust spiking in PKC-δ+ neurons (Fig. 4a).
Bilateral optogenetic activation of CEl PKC-δ+ neurons in vivo at 5 Hz (see Methods), a
spiking rate comparable to that measured for these neurons in vivo20,32, strongly inhibited
food intake during a 20 min test in 24 h food-deprived mice (Fig. 4b). Normal feeding
resumed after the offset of photostimulation (Fig. 4b, orange bar). A similar inhibition was
observed in fed mice (Fig. 4c), while controls expressing hrGFP in PKC-δ+ neurons showed
no effect (Fig. 4b, c). Photoactivation of PKC-δ+ neurons also interrupted ongoing feeding
in the home cage within a few seconds following the onset of photostimulation (Fig. 4d, e,
and Movie S1). Activation also transiently inhibited drinking in water-deprived mice,
although this effect was modest, and, in contrast to the effect on food intake, was only
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observed during the first few minutes of the 20 min test (Supplementary Fig. 3c-g).
Importantly, feeding inhibition by PKC-δ+ neuron activation was not rescued when drinking
water was provided (Supplementary Fig. 3h), suggesting that the suppression of food intake
is not due to increased thirst.
To gain more insight into the inhibitory effect of CEl PKC-δ+ neurons on feeding, we
performed a time-resolved analysis of feeding in 24 h food-deprived mice. This analysis
revealed that activation of CEl PKC-δ+ neurons increased the latency to approach the food
(Fig. 4f, g; “approach” defined as when the animal's nose touched the food pellet), and
decreased the number of approaches (Fig. 4f, h). Thus, activation of CEl PKC-δ+ neurons
inhibited both the appetitive and consummatory phases of feeding behavior. Importantly,
mating behavior towards a female intruder mouse was not affected (Supplementary Fig. 3i),
suggesting that PKC-δ+ neurons do not inhibit approach to any appetitive stimulus, but
specifically inhibit approach to food resources.
Activation of CEl PKC-δ+ neurons does not increase anxiety
The CEA is well known to promote anxiety and fear33-35. This raised the possibility that
activation of CEl PKC-δ+ neurons could inhibit feeding indirectly, by promoting anxiety or
fear. Several lines of evidence suggest that this is not the case. First, in three different assays
of anxiety, including the elevated plus maze, open field test and light-dark box test,
optogenetic activation of CEl PKC-δ+ neurons was anxiolytic rather than anxiogenic (Fig.
5a-c). Second, the inhibition of feeding caused by optogenetic activation of CEl PKC-δ+
neurons was not reversed by the anxiolytic drug diazepam (DZ; Fig. 5d), although DZ did
increase food intake in control mice (Fig. 5e). Third, activation of CEl PKC-δ+ neurons did
not promote freezing or reduced locomotion (Supplementary Fig. 4a-b). Finally, activation
did not produce conditioned place aversion, a measure of discomfort or unpleasantness36
(Supplementary Fig. 4c-e). These data suggest that the anorexic effect of CEl PKC-δ+
neuronal activation is unlikely to be due to increased fear or anxiety
To investigate whether CEl PKC-δ+ neuron activation might inhibit feeding by promoting
visceral malaise, we asked whether it could serve as an unconditional stimulus (US) in
conditioned taste aversion (CTA) assays. Stimuli such as LiCl that cause visceral malaise
are able to act as a US in such assays24. However, activation of PKC-δ+ neurons did not
promote CTA, although in parallel controls LiCl administration to mice expressing hrGFP in
CEl PKC-δ+ neurons did serve as an effective US for CTA (Supplementary Fig. 4f). This
positive control indicates that expression of virally encoded proteins in these neurons does
not interfere with CTA per se. Together, these data suggest that activation of PKC-δ+
neurons does not inhibit feeding by promoting visceral malaise.
Monosynaptic anorexigenically activated inputs to PKC-δ+ neurons
The observation that CEl PKC-δ+ neurons are activated by, and required for the effect of,
several types of anorexigenic agents raised the question of the circuits through which these
agents act on these neurons. To address this question, we performed Cre-dependent, rabies
virus-based monosynaptic retrograde tracing from CEl PKC-δ+ neurons37,38, in combination
with c-Fos labeling following treatment with anorexigenic agents (Fig. 6, Supplementary
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Fig. 5 and 6). On the one hand, these agents might all act through a final common pathway
pre-synaptic to CEl PKC-δ+ neurons, in which case c-Fos+ neurons in a single location
would be retrogradely labeled (Supplementary Fig. 6a, left); on the other hand, if c-Fos+
neurons in multiple areas were retrogradely labeled, it would suggest convergence from
several pathways onto CEl PKC-δ+ neurons (Supplementary Fig. 6a, right).
These experiments yielded retrogradely labeled (GFP+) cells within CEA itself, as well as in
the basolateral amygdala (BLA), insular cortex, lateral parabrachial nucleus (LPB), and
several other brain regions (Supplementary Fig. 5). Moreover, different anorexigenic agents
activated c-Fos expression (relative to saline-injected controls) in these retrogradely labeled
cells, in a combinatorial manner: LiCl and quinine induced c-Fos expression in Rabies-GFP+
neurons in all of these areas (LPB, BLA, and insula), while CCK induced c-Fos expression
in retrogradely labeled neurons within the LPB and BLA, but not in the insula (Fig. 6a-j,
Supplementary Fig. 6 and 7). Slice recordings using ChR2 assisted circuit mapping39
confirmed that CEl PKC-δ+ neurons receive monosynaptic excitatory inputs from the insula
and LPB (Supplementary Fig. 8a-g). Taken together, these data argue against the idea that
the upstream neurons activated by these anorexigenic agents converge on a common target
pre-synaptic to CEl PKC-δ+ neurons, but rather that they converge on PKC-δ+ neurons
themselves (Supplementary Fig. 6a, right).
Recently, Carter et al. showed that activation of CGRP+ neurons in the LPB inhibits feeding,
and that this inhibition is mediated by projections to CEl5. Cre-dependent monosynaptic
retrograde tracing from CEl PKC-δ+ neurons combined with anti-CGRP immunostaining
revealed that over 60% of retrogradely labeled LPB neurons were CGRP+ (Fig. 6k). These
data suggest that PKC-δ+ neurons are synaptic targets of CGRP+ LPB neurons that project to
CEl, but are also targets of CGRP-LPB neurons. Consistent with these retrograde tracing
experiments, slice recordings revealed that CEl PKC-δ+ neurons receive excitatory inputs
from the LPB (Supplementary Fig. 8e-g).
Local CEA inhibitory circuits mediate feeding inhibition
As a first step towards investigating the circuit-level mechanisms through which CEl PKC-
δ+ neurons might exert their inhibitory influence on feeding, we mapped their downstream
projections using Cre-dependent fluorescent tracers40. These experiments revealed local
projections of PKC-δ+ neurons in CEA (lateral and medial subdivisions), as well as longer-
range projections to the bed nucleus of the stria terminalis (BNST) and the LPB
(Supplementary Fig. 8h). Using ChR2-assisted circuit mapping39, we confirmed that CEl-
PKC-δ+ neurons mono-synaptically inhibit PKC-δ− CEA neurons20,32 (20 out of 20 neurons
tested evoked IPSCs, inhibitory postsynaptic currents), as well as BNST neurons (IPSCs
evoked in 9 out of 10 neurons); however inhibition of LPB neurons was weak (only 1 out of
6 neurons showed a small IPSC) (Supplementary Fig. 8i-n).
To determine which of these outputs might contribute to the influence of CEl PKC-δ+
neurons on feeding, we first optogenetically activated the projections of these neurons to the
LPB and BNST35. No inhibition of feeding was observed (n = 5 animals tested for each
projection; data not shown). To test whether intra-amygdalar inhibition is involved, we
bilaterally infused the GABAA receptor antagonist bicuculline into CEA while
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optogenetically activating PKC-δ+ neurons (Fig. 7a). Amygdala acute slice recordings
indicated that bicuculline blocked IPSCs in PKC-δ− neurons evoked by optogenetic
activation of PKC-δ+ neurons (Fig. 7b). Photostimulation-induced inhibition of food intake
was blocked by bicuculline infusion (Fig. 7c), suggesting that local GABAergic signaling in
CEA is required for the inhibitory influence of GABAergic PKC-δ+ neurons on feeding.
The preceding results prompted us to investigate the intra-amygdalar targets through which
PKC-δ+ neurons might inhibit feeding. As described earlier, inhibition of these neurons
using hM4Di not only reduced c-Fos induction in PKC-δ+ cells by anorexigenic signals, but
concurrently increased c-Fos expression in CEl PKC-δ− neurons (Supplementary Fig. 2).
These data, and the fact that CEl PKC-δ+ neurons monosynaptically inhibit CEl PKC-δ−
neurons20,32 (Fig. 7b), raised the possibility that the latter neurons exert an influence on
feeding opposite to that of PKC-δ+ neurons. If so, then inhibition of these PKC-δ− neurons
might inhibit feeding, similar to the effect of activating CEl PKC-δ+ neurons.
To test this hypothesis, we used a “Cre-out” strategy, in which PKC-δ-Cre mice were
injected in CEA with an rAAV designed so that Cre recombinase excises, rather than
activates, the eNpHR3.0 coding sequence41 (Fig. 7d). In this way, PKC-δ− neurons in CEA,
rather than PKC-δ+ neurons, should express eNpHR3.0 (Fig. 7d). Slice recordings
confirmed photostimulation-dependent silencing of PKC-δ− neurons, while PKC-δ+ neurons
were not obviously affected (Fig. 7d, traces, and Methods). Food intake in 24 h food-
deprived mice was partially but significantly inhibited upon silencing PKC-δ− neurons in
vivo (Fig. 7e), in a manner that scaled with the level of eNpHR3.0 expression in CEl
(Supplementary Fig. 9). These data support the idea that CEl PKC-δ− neurons exert a net
positive influence on feeding, in contradistinction to PKC-δ+ neurons.
To extend this result, we asked whether activation of PKC-δ− neurons might, conversely,
increase food intake. To do this, we first activated genetically defined subsets of CEl PKC-
δ− neurons using two different Cre lines: Tac2-Cre (obtained from the Allen Institute for
Brain Science; http://connectivity.brain-map.org/transgenic/experiment/131034318) and
CRF-Cre42 (of which 50% and 70% are PKC-δ−, respectively; Supplementary Fig. 10a-c).
However optogenetic activation of these neurons yielded neither increased nor decreased
feeding (Supplementary Figure 10d-g). To activate other populations of CEl PKC-δ−
neurons that might not be covered by these Cre lines, we expressed ChR2 in them using the
same “Cre-out” approach41 described earlier for eNpHR3.0 (Fig. 7f). Activation of these
PKC-δ− neurons neither increased food intake in 24 h fasted nor in fed mice (Fig. 7g, h).
This may reflect a ceiling effect on feeding, or incomplete elimination of ChR2 expression
from PKC-δ+ neurons that exert a counteracting influence.
Since inhibition of PKC-δ+ neurons likewise failed to increase food intake in 24 h fasted
mice, but reversed the inhibitory effect of some anorexigenic agents (Fig. 2b), we asked
whether activation of PKC-δ− neurons would similarly attenuate the effects of anorexigenic
agents. Indeed, optogenetic activation of CEA PKC-δ− neurons significantly rescued the
inhibition of feeding by CCK, although complete recovery of food intake to control levels
was not achieved (Fig. 7h). Inhibition of feeding by LiCl was not significantly rescued (not
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shown). These data suggest that the influence of at least one anorexigenic signal (CCK) may
be exerted, at least in part, through inhibition of CEA PKC-δ− neurons.
Discussion
CEl PKC-δ+ and PKC-δ− neurons exert opposing influences on feeding
Although the CEA has been implicated in the control of feeding, prior results have been
contradictory, likely reflecting the cellular heterogeneity of this structure20-22 and the
inadequate specificity of the perturbational methods used. Here we show that PKC-δ+
neurons in CEl play a central role in mediating the inhibitory influence on feeding of diverse
anorexigenic signals, as well as in satiety, and can exert a profound and rapid inhibitory
influence on feeding when activated. We also show that some CEA PKC-δ− neurons may
exert an opposite-direction influence on feeding (although the resolution of our method does
not allow us to distinguish whether these neurons are in CEl, CEm or both). Furthermore,
both populations mediate the influence of some anorexigenic agents to suppress food intake,
but in opposite directions: PKC-δ+ neurons must be active, while PKC-δ− neurons must be
inhibited, to achieve complete suppression of feeding. These functional data are consistent
with our observation that anorexigenic agents increase c-Fos expression in CEl PKC-δ+
neurons and reduce its expression in PKC-δ− neurons (Supplementary Fig. 2). The presence
of intermingled populations of neurons in CEA with opposing influences on feeding may
explain previous inconsistencies in the literature.
CEl PKC-δ+ neurons as a locus for multiple anorexigenic influences
CEl PKC-δ+ neurons are activated by multiple anorexigenic signals, as well as by bitter
tastants and satiety. Inhibition of these neurons impairs the influence of some but not all
anorexigenic agents tested (CCK and LiCl, but not LPS which induces a wide range of
inflammatory and sickness response25,26). It also blocks the influence of quinine, a bitter
tastant, to inhibit feeding and increases the time to satiation in food-deprived animals. Taken
together, these data suggest that PKC-δ+ neurons mediate the effects of multiple (but clearly
not all) inhibitory influences on feeding. This finding raises the question of whether these
influences converge on a final common input to PKC-δ+ neurons, or rather act through
multiple, parallel circuits that converge at the level of these neurons themselves. Our
combined c-Fos and monosynaptic retrograde tracing data argue against the former, and in
favor of the latter possibility. However further studies will be required to determine whether
each of these upstream inputs acts through the same or through different PKC-δ+ neurons.
A recent study has shown that LPB CGRP+ neurons inhibit feeding via projections to CEl5.
Our data indicate that ∼60% of LPB inputs to PKC-δ+ neurons derive from CGRP+ neurons.
Whether the CEl PKC-δ+ neurons that receive input from CGRP+ neurons are activated by
anorexigenic agents and mediate feeding inhibition, and whether inputs from CGRP- LPB
neurons also inhibit feeding via inputs to these neurons, is unclear and remains to be
investigated. We note, moreover, that LPB CGRP+ neurons mediate the anorexigenic
influences of LiCl and LPS but not CCK5, while CEl PKC-δ+ neurons mediate the inhibitory
influences of CCK and LiCl, but not LPS. This suggests that other inputs to PKC-δ+ neurons
may mediate the inhibitory influence of CCK, and that the LPB represents but one of
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multiple anorexigenic pathways that converge on these CEl neurons. Interestingly, our
ChR2-assisted circuit-mapping studies indicated that most if not all of the upstream inputs to
PKC-δ+ neurons that we have tested are excitatory. The fact that these CEl neurons are
GABAergic suggests, therefore, that they may represent the first inhibitory relay in the
central processing of inhibitory influences on food intake.
CEl PKC-δ+ neurons, feeding and fear
The CEA is thought to be involved in promoting a variety of aversive states, including fear,
anxiety, and visceral malaise33-35,43. Because fear and anxiety reduce appetitive behaviors,
including feeding, it was possible that activation of CEl PKC-δ+ neurons might inhibit
feeding indirectly, by promoting such aversive states. However, using multiple behavioral
assays of fear and anxiety, we found no evidence that activation of CEl PKC-δ+ neurons,
under conditions that inhibit feeding, makes mice more fearful or anxious; to the contrary
the influence of their activation is anxiolytic. These data are consistent with previous studies
indicating that CEl PKC-δ+ neurons exert an inhibitory influence on conditioned fear20.
Moreover, innate fear, as expressed by unconditional freezing, was not evoked by
optogenetic activation of PKC-δ+ neurons at frequencies that inhibit feeding. Finally, while
fear and anxiety not only inhibit feeding, but also other appetitive behaviors such as mating,
activation of CEl PKC-δ+ neurons, in contrast, had no inhibitory effect on mating.
These data not with standing, we cannot exclude the possibility that the optogenetic
activation of PKC-δ+ neurons inhibits feeding indirectly, via an influence on some other
behavioral or motivational state that in turn reduces food intake. For example, the CEA also
plays a role in autonomic processes such as the control of heart rate and blood pressure33,
and we have not ruled out that the effect of CEl PKC-δ+ neuron activation to inhibit feeding
may involve some of these physiological influences. Nevertheless, the fact that PKC-δ+
neurons are activated by anorexigenic drugs in vivo, and, most importantly, that inhibiting
these neurons reduces the anorexigenic influence of some of these drugs, makes it more
likely, in our opinion, that these neurons play a role in mediating the influence of certain
anorexigenic signals.
The relationship between the CEl PKC-δ+ neurons involved in the control of feeding, and
those involved in the regulation of conditioned fear20, remains to be established. Our c-Fos
data indicate that ∼20-25% of PKC-δ+ neurons are activated by anorexigenic drugs
(Supplementary Fig. 1). This 20-25% may represent a deterministic subset of the PKC-δ+
population. In other words, there may be different subsets of CEl PKC-δ+ neurons that
regulate the expression of conditioned fear, and the influence of anorexigenic agents,
respectively. Our previous study provided evidence of molecular heterogeneity within the
CEl PKC-δ+ population: for example, 40% of these neurons express the neuropeptide
enkephalin, while 65% express the oxytocin receptor20. Whether such heterogeneity is
relevant to the control of fear vs. feeding is not clear. Alternatively, a common or
overlapping set of PKC-δ+ neurons in CEl may play a role in both fear and in feeding,
according to their state of activity and/or the functional networks in which they participate.
Further studies will clearly be required to resolve these alternatives.
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How do CEl PKC-δ+ neurons inhibit feeding?
The neural circuits through which CEl PKC-δ+ neurons exert their inhibitory influence on
feeding remains to be established. Because feeding is promoted by hypothalamic structures
such as the arcuate nucleus (Arc) and lateral hypothalamus (LH)1-3, it seems likely that
direct or indirect projections from CEA to these structures are involved in the inhibition of
feeding. Whether these projections derive from CEl PKC-δ+ neurons, or from other CEA
populations that are targets of PKC-δ+ neurons, is not yet clear. It has recently been shown
that GABAergic neurons in BNST promote feeding via projections to the LH46. Because
CEl PKC-δ+ neurons project to, and make inhibitory synapses in, the BNST it is attractive to
think that these GABAergic neurons might suppress feeding via inhibition of LH-projecting
BNST neurons. However, our attempts to inhibit feeding by stimulating CEl PKC-δ+ neuron
projections to the BNST were unsuccessful, although we cannot rule out technical reasons
for this negative result (e.g., insufficient levels of ChR2 expression in projections).
While other extra-amygdalar projections of CEl PKC-δ+ neurons (http://connectivity.brain-
map.org) may be involved in feeding suppression, these neurons also make extensive
projections within the amygdala. We found that local infusion of bicuculline in CEA can
block feeding inhibition caused by optogenetic activation of PKC-δ+ neurons. This epistasis
suggests that intra-amygdalar GABAergic synapses made by PKC-δ+ neurons are required
for their anorexigenic function, although we cannot rule out an indirect effect due to dis-
inhibition of other neighboring amygdala populations. Whether these synapses inhibit
amygdalar subpopulations that make long-range (direct or indirect) projections to feeding
centers, or rather minimize local feedback inhibition onto PKC-δ+ neurons, e.g., from CEl
PKC-δ− neurons20,32 is not clear and will require further study.
The studies presented here have identified a population of central amygdale GABAergic
neurons that plays an important role in mediating the influence of signals that inhibit feeding
behavior. The fact that optogenetic activation of these neurons strongly reduces food intake
further suggests that these cells could provide a target for novel therapeutic interventions to
treat obesity, anorexia or other eating disorders.
Online Methods
All experimental protocols were conducted according to US National Institutes of Health
guidelines for animal research and were approved by the Institutional Animal Care and Use
Committee (IACUC) at the California Institute of Technology.
Mice—Male mice were housed on a 12 hour light (7 am)/dark (7 pm) cycle with ad libitum
access to water and rodent chow (Lab Diet, 5001) unless otherwise noted. Male mice were
used for all the behavioral experiments, male and a few female mice were used in brain slice
electrophysiology. Ai14 Cre-reporter mice47 have been described previously.
Virus—All the AAV viruses were produced at the Gene Therapy Center Vector Core in the
University of North Carolina at Chapel Hill. Rabies virus were purchased from Salk Gene
Transfer, Targeting and Therapeutics Core. Behavioral experiments were usually performed
4 weeks after virus injection. For rabies virus tracing, AAV1-EF1α-FLEX-TVAmCherry
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and AAV1-CA-FLEX-RG were mixed at a ratio of 1:4 and then injected in CEA; around 3
weeks later, EnvA G-deleted Rabies-GFP were injected in the same place; 5 - 6 days later,
mice were perfused and their brains were sectioned to check the monosynaptic upstream
neurons. Each virus and its serotype were indicated in the main text.
Animal surgery—Mice survival surgeries were performed as described previously48.
Briefly, mice 2-4 months old were deeply anaesthetized with 5% isoflurane in oxygen and
kept at 1.5% isoflurane during surgery. Surgery was performed with a stereotaxic frame
(Kopf). Viral injection coordinates (in mm, midline, Bregma, dorsal surface): CEA (±2.85,
-1.40, -4.72), LPB (±1.50, -5.30, -3.40), LH (±1.20, -1.55, -5.20), ventral BNST (±1.00,
+0.05, -4.70), insula (±3.90, +0.05, -4.00). Ferrule fibers were implanted ∼0.5 mm above
the injection sites. After ferrule fiber implanted, dental cement (Metabond) was used to
anchor the fiber to the skull. For behavioral experiments that require drug infusion, guide
cannulas (26 G, PlasticsOne) were implanted ∼0.8 mm above the injection sites. Mice were
single housed after surgery. At least 3-4 weeks were allowed for mice recovery and viral
expression after surgery.
In vivo photostimulation—Several lasers (Shanghai DreamLaser: 473 nm, 50 mW; 593
nm, 50 mW; Crystal Laser: 445 nm, 50 mW; 473 nm, 50 mW; 561 nm, 50 mW) were used
to deliver light. An Accupulser Signal Generator (World Precision Instruments, SYS-A310)
were used to control the frequency and pulse width of the laser light. Light was delivered to
the brain through an optic fiber (200 μm diameter core, NA 0.22, Doric Lenses) connected
with the implanted ferrule fiber by a zirconium sleeve. The light power in the brain regions
0.5 mm below the fiber tip was calibrated according to the description49. The calibrated light
power density (0.5 mm below the fiber tip) used in light activation experiment was 5-6
mW/mm2. A 5 Hz, 10 ms pulse width light were used in all the optogenetic activation
experiments.5 Hz light stimulation was used because (1) PKC-δ+ neurons show an average
firing rate of 3-5 Hz in in vivo recordings50, (2) CEA neurons fires at a rate of less than 5 Hz
at innocuous stimulus while fires more than 10 Hz in response to noxious stimuli51, (3)
PKC-δ+ neurons can be triggered robustly to fire action potentials by ≤ 10 Hz light pulses as
shown by whole-cell patch clamp slice recordings48.
Continuous light illumination in the brain over a long time generates heat52, so pulsed light
was used for optogenetic silencing during the 20 min feeding test. And because PKC-δ+
neurons do not have rebound firing after the light is off as tested in slice recording (Fig. 3a),
a protocol of alternating 20 seconds light on and 10 seconds light off was used to silence
CEl PKC-δ+ neurons (Fig. 3b). Because some type of PKC-δ− neurons have rebound firing
after hyperpolarization48, a different protocol of 20 Hz, 20 ms light pulse (calibrated light
power in CEA, ∼ 2 mW/mm2) was used to silence PKC-δ− neurons (Fig. 7d). As tested in
brain slices, neurons expressing eNpHR3.0 can be hyperpolarized by different wavelengths
(we tested 445 nm, 473 nm, 561 nm, 593 nm, and 633 nm); and because mice eat normally
with 20 Hz, 20 ms 593 nm light pulses at a power less than 10 mW/mm2 (food intake in
mice with light: 0.29 ± 0.03 g; food intake in mice without light: 0.30 ± 0.02 g; t test, p =
0.78.); we use the food intake when mice were implanted with optic fiber but received no
light as control (Fig. 6e).
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Pharmacology—CNO (Enzo life science-Biomol, BML-NS105-0005) were freshly
dissolved in injection saline (0.9% NaCl) and intraperitoneally injected at 5 mg/kg for
hM4Di silencing, or 2 mg/kg for hM3Dq activation. Other compounds used for
intraperitoneal injection: CCK (5 μg/kg, Tocris), Diazepam (1 mg/kg or 2 mg/kg, Hospira),
LiCl (150 mg/kg, Sigma, prepared in 150 mM), LPS (0.1 mg/kg, Sigma, L4516-1MG).
Behavioral test were usually performed 20-30 min after drug injection.
Behavioral tests
Feeding behavior—For 24 h fasted feeding test, mice were food-deprived the day before
test. Mice were briefly anaesthetized with isoflurane and coupled with optic fibers. 15 min
after recovery, mice were introduced into a novel empty cage with a regular food pellet (Lab
Diet, 5001), and allowed for feeding for 20 min. The weight of the food pellet, including the
food debris left in the cage floor after test, was measured to calculate the food intake. For
fed feeding test, mice were not food deprived before feeding test. For optogenetic
experiments, the light was started just before the mice were introduced into the testing cage.
The feeding behavior was videotaped and manually analyzed. For pharmacogenetic
experiments, CNO was injected 20 min before the feeding test. All the feeding test were
performed between 2 pm and 7 pm. Bitter food was prepared by immersing regular food
pellets in 10 mM quinine (Sigma) solution for 10 min and dried overnight, and the control
taste food was prepared by immersing the food pellets in dH2O for 10 min and dried
overnight. In the conditioned taste aversion experiment (Supplementary Fig. 4f), bacon taste
food pellets (Newco Distributors, 10 mg Tablet) were used as a novel taste food.
Intraoral infusion—A standard ball-tipped gavage needle was put just in the mouth and
∼0.2 ml water was slowly infused in ∼15 seconds. To induce c-Fos expression by bitter
tastant, mice were oral-infused with ∼0.2 ml 10 mM quinine solution for 15 seconds,
animals infused with water or 0.5 M sucrose solution were used as controls. Mice were
perfused 1-1.5 hour after infusion.
Anxiety test—Standard elevated plus maze, open field, and light/dark box were used. A
platform (74 cm above the floor) with two opposing open arms (30 × 5 cm) and two
opposing closed arms (30 × 5 × 14 cm) was used as elevated plus maze. Mice were placed
into the center of the plus and their behavior was tracked for 5 min. A square plastic box (50
× 50 × 30 cm, a 25 × 25 cm square center was defined as “center” in analysis) was used as
open box. Mice were placed individually in the center of the box, and their behavior was
tracked for 10 min. A plastic box consisting of a dark (black with cover, 16 × 50 cm) and a
bright (white no cover, 34 × 50 cm) compartment, which are connected by a central opening
(7 × 14 cm) at the floor level, was used as a light/dark box. Mice were placed individually in
the center of the light area. The behavior was tracked for 10 min. All the behaviors were
videotaped and analyzed offline with Ethovision.
Place preference test—Place preference test were performed with a three-chamber
system described previously53, in which Chamber A and Chamber B have different visual
and tactile cues by having distinct walls and floors, while the center chamber is a neutral
plastic enclosure. Mice were allowed to explore all three chambers for 15 min on day 1, and
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restricted in either chamber A or B for 20 min with light delivered on day 2. Mice were then
allowed to explore all three chambers for 15 min on day 4. The behavior were videotaped
and analyzed offline with Ethovision.
Behavioral tests were performed by an investigator with knowledge of the identity of the
experimental groups versus control groups.
Immunohistochemistry and histology—All mice after behavioral test were perfused
and checked for virus expression and implanted fiber or cannula location. For
immunofluorescent staining, mice were transcardially perfused with 20 ml PBS followed by
20 ml 4% paraformaldehyde in PBS. For cryosection staining, brains were dissected out and
immersed in 15% sucrose overnight. Cryosections of 30 μm thickness were processed. For
the vibratome sectioning, brains were removed and postfixed in 4% paraformaldehyde
overnight, then the section were cut with a vibratome (Leica, VT1000S) at 100 μm
thickness. Sections were stained with primary antibody at 4 °C overnight, in a blocking
solution contains 1% BSA or 5% donkey serum and 0.5% Triton X-100. After 3 × 10 min
wash in PBS, standard Alexa Fluor secondary antibodies (Invitrogen, 1:250) were used at
room temperature for 1 hour. Sections were then washed 3 × 10 min in PBS and mounted in
Fluo Gel (17985-10; Electron Microscopy Sciences, with DAPI) and viewed under an
Olympus confocal microscope. Primary antibodies used: mouse anti-PKC-δ (BD
Biosciences, 610398, 1:500), rabbit anti-CGRP (Bachem, T4032, 1:500), goat anti-c-Fos
(Santa Cruz Biotech, sc-52-G, 1:250).
Electrophysiological slice recordings—Mouse brain slice was prepared as
described48. In brief, mouse coronal sections of 250 μm thickness were cut with a vibratome
(Leica, VT1000S), using ice-cold glycerol-based ACSF containing (in mM): 252 glycerol,
1.6 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 18 NaHCO3, 11 Glucose, oxygenated in
carbogen (95% O2 balanced with CO2) for at least 15 min before use. Slice were recovered
for at least 1 hour at 32°C and then kept at room temperature in regular ACSF containing (in
mM): 126 NaCl, 1.6 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 18 NaHCO3, 11 Glucose,
oxygenated with carbogen. The fluorescence of the cells were detected by a fluorescence
video microscopy (Olympus BX51). Whole-cell voltage, current clamp, or cell-attached
recordings were performed with a MultiClamp 700B amplifier and Digidata 1440A
(Molecular Devices). The patch pipette with a resistance of 5-8 MΩ was filled with an
intracellular solution containing (in mM): 135 potassium gluconate, 5 EGTA, 0.5 CaCl2, 2
MgCl2, 10 HEPES, 2 MgATP and 0.1 GTP, pH 7.2, 290–300 mOsm. Data were sampled at
10 kHz, filtered at 3 kHz and analyzed with pCLAMP10 software.
For photostimulation in brain slice, several lasers (Shanghai DreamLaser, 473 nm, 50 mW;
593 nm, 50 mW; Crystal Laser, 561 nm, 50 mW) were used to deliver pulsed light or
continuous light, the typical power at the specimen ranges from 0.1 to 10 mW/mm2, as
measured with a photodiode. In ChR2 assisted circuits mapping experiments, 2 ms light
pulses were used to trigger IPSC or EPSC, and a 0.1 μs 0.1 mV was applied at the same time
of light trigger to help identify the start of light pulse.
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Statistics—Data are represented as means ± s.e.m. or box-and-whister plots. P value were
calculated by paired (within subjects comparisons) or un-paired (between subjects
comparisons) Student's t-test, and a value of smaller than 0.05 was consider significant. For
comparisons across more than two groups, data were analyzed using one-way ANOVA and
adjusted with the Bonferroni's correction. For data with more than one independent variable,
two-way ANOVA was used. Each test and significance were indicated in figure legends.
Data were analyzed with GraphPad Prism Software.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. CEl PKC-δ+ neurons are activated by diverse anorexigenic signals
a, d-e. Representative histology (a) and quantification (d-e) of c-Fos like immunoreactivity
in CEl after intraperitoneal injection of saline, CCK, LiCl, or LPS. b, f-g. Histology (b) and
quantification (f-g) of CEl c-Fos expression in 24 h fasted mice with or without 3 hr
refeeding. c, h-i. Histology (c) and quantification (h-i) of CEl c-Fos expression in mice with
oral infusion of water, quinine, or sucrose solution. Box plots (d, f, h) show mean (+),
median, quartiles (boxes), and range (whiskers) in each CEl brain section; Values in (e, g, i)
are means ± s.e.m. n = 6 – 17 brain sections from 4 – 5 animals in each condition. One-way
ANOVA (F(3, 24) = 45.5, p < 0.0001 (d); F(2, 36) = 73.2, p < 0.0001 (h)) with post-hoc
Bonferroni t-test indicated a significant difference between the saline-injected and drug-
injected groups; Unpaired t-tests are used in (e), t(12) = 6.85, p < 0.0001 (CCK), t(12) =
7.03, p < 0.0001 (LiCl), t(14) = 1.00, p = 0.33 (LPS); t(30) = 8.43, p < 0.0001 (f); t(32) =
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8.09, p < 0.0001 (re-fed) (g); t(28) = 3.42, p = 0.0019 (quinine) (i). n.s. not significant, ** p
< 0.01, *** p < 0.001.
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Figure 2. Activity of CEl PKC-δ+ neurons is required for the influence of anorexigenic agents
a. Cell-attached slice recording from a CEl PKC-δ+ neuron expressing hM4Di-mCherry that
is silenced by bath application of CNO. b. Food intake in 24 h fasted animals after
administration of different anorexigenic agents. The number of animals in each condition is
indicated in the bars. Values are means ± s.e.m.. Two-way ANOVA with post-hoc
Bonferroni t-tests showed a significant effect of CNO silencing, F(1, 24) = 0.363, p = 0.55
(saline); F(1, 31) = 11.7, p = 0.0018 (CCK); F(1, 30) = 4.50, p = 0.042 (LiCl); F(1, 32) =
0.001, p = 0.98 (LPS). c. Intake of control vs. quinine-laced food in 24 h fasted animals
expressing hrGFP (n = 5 animals) or hM4Di (n = 5 animals), after intraperitoneal injection
of CNO. Note that addition of quinine (bitter) inhibited food intake in controls. Values are
means ± s.e.m.. Two-way ANOVA (F(1, 16) = 9.91, p = 0.0062) with post-hoc Bonferroni t-
test showed a significant effect of silencing. d. Food intake in CNO-treated fed mice
expressing hrGFP (n = 13 animals) or hM4Di (n = 14 animals) in CEl PKC-δ+ neurons. Box
plots show mean (+), median, quartiles (boxes), and range (whiskers). Unpaired t-test, t(25)
= 2.2, p = 0.045. n.s., not significant; * p < 0.05, ** p < 0.01.
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Figure 3. Optogenetic silencing of CEl PKC-δ+ neurons increases food intake in fed mice
a-b. Sample slice recordings from PKC-δ+ neurons expressing eNpHR3.0; orange lines, 593
nm light. See Methods for further details. c. Diagram illustrating bilateral optogenetic
silencing of CEl PKC-δ+ neurons (red). d. Food intake in fed animals. e-i. Raster plot of
bouts (e), latency to the first feeding bout (f), number of bouts (g), bout duration (h), and
cumulative bouts (i) in fed animals expressing hrGFP or eNpHR3.0 in CEl PKC-δ+ neurons.
Solid lines in (i) are fits using the equation Bt=Bmax * (1-1/[1+(t-Ti)/T0.5]), where Bt is the
cumulative number of bouts at time t; T0.5 is the time to reach the half maximal value of B,
(Bmax, plateau phase), T0.5(eNpHR) = 8.2 min, T0.5(hrGFP) = 4.2 min; Ti is the time at which
feeding is initiated. n = 7 animals in each group. Box plots show mean (+), median, quartiles
(boxes), and range (whiskers). Values in (i) are means ± s.e.m.. Unpaired t-test, t(12) = 2.5,
p = 0.026 (d); t(12) = 1.4, p = 0.18 (e); t(12) = 3.5, p = 0.0048 (f); t(12) = 0.24, p = 0.82 (g).
* p< 0.05, ** p < 0.01.
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Figure 4. Activation of CEl PKC-δ+ neurons inhibits feeding
a. Brain slice whole-cell patch clamp recording traces showing action potentials triggered in
PKC-δ+ neurons expressing ChR2 by 5 Hz, 10 ms 473 nm laser pulses. b-c. Food intake by
24 h fasted (b) and fed (c) animals expressing control protein hrGFP (n = 4) or ChR2 (n =
5). Mice expressing ChR2 were allowed to continue feeding for an additional 20 min after
photostimulation offset (b, orange bar, n = 4). One-way ANOVA adjusted with Bonferroni's
correction, F(2, 10) = 45.1, p < 0.0001 (b); Unpaired t-test, t(7) = 8.02, p < 0.0001 (c). d.
Raster plots showing feeding episodes by one animal in its home cage. Activation light (473
nm) or control light (571 nm) was triggered 1-2 seconds after feeding began. 5 Hz, 10 ms
light pulses were delivered for 10 seconds. e. Latency to stop feeding in response to
photostimulation. n = 8 (control), and 11 (activation) trials from 4 animals. Unpaired t-test,
t(17) = 3.15, p = 0.0058. f. Raster plot of food approaches in 24 h fasted animals. g. Latency
of the first approach to food. Unpaired t-test, t(7) = 2.9, p = 0.022. h. Number of food
approaches during a 20 min test. Unpaired t-test, t(7) = 3.6, p = 0.0083. Box plots show
mean (+), median, quartiles (boxes), and range (whiskers). n.s., not significant; * p < 0.05,
** p < 0.01, *** p < 0.001.
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Figure 5. Activation of CEl PKC-δ+ neurons does not increase anxiety
a-c. Optogenetic activation of PKC-δ+ neurons during elevated plus maze (a), open field test
(b), and light-dark box test (c). n = 5 mice expressing ChR2 and n = 4 - 7 mice expressing
control protein hrGFP. Box plots show mean (+), median, quartiles (boxes), and range
(whiskers). Unpaired t-test, t(7) = 4.01, p = 0.0051 (a, in open arm); t(7) = 0.014, p = 0.99
(a, open arm entries); t(7) = 1.12, p = 0.30 (a, velocity); t(7) = 1.12, p = 0.30 (a, distance
moved); t(7) = 2.74, p = 0.029 (b, in center, 0 – 2 min); t(7) = 1.04, p = 0.33 (b, in center, 0
– 10 min); t(7) = 0.60, p = 0.57 (b, velocity, 0 – 10 min); t(7) = 0.60, p = 0.57 (b, distance
moved, 0 – 10 min); t(7) = 2.50, p = 0.031 (c, in light box), t(7) = 0.14, p = 0.90 (c, dark box
entries). d. Food intake after injection of the anxiolytic drug diazepam (DZP). n = 4 (no
light), 5 (light), 5 (light+ DZP) mice expressing ChR2 in each group. One-way ANOVA
(F(2, 13) = 44.5, p < 0.0001) with post-hoc Bonferroni t-test indicated. e. Diazepam injected
at a dose of 1 mg/kg increases food intake in wild type animals. n = 4 animals in each group.
Unpaired t-test, t(6) = 2.78, p = 0.032. Values are means ± s.e.m.; n.s., not significant; * p <
0.05, ** p < 0.01, *** p < 0.001.
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Figure 6. Identification of monosynaptic inputs to CEl PKC-δ+ neurons that are activated by
anorexigenic drugs
a. Virus injection procedure for rabies retrograde tracing. b-j. Quantification of c-Fos
expression and GFP double-labelling in LPB (b-d), BLA (e-g), and insula (h-j).
Representative histology is shown in Supplementary Fig. 6. n = 6 sections from two
injection experiments in each group. One-way ANOVA (F(2, 15) = 23.1, p < 0.0001 (c);
F(2, 15) = 12.0, p = 0.0008 (d); F(2, 15) = 42.4, p < 0.0001 (f); F(2, 15) = 25.1, p < 0.0001
(g); F(2, 15) = 14.6, p = 0.0003 (i); F(2, 15) = 18.8, p < 0.0001 (j)) with post-hoc Bonferroni
t-test shows significant differences between groups (asterisks). k. Histology of rabies-GFP+
(monosynaptic retrograde labeling from CEl PKC-δ+ neurons) and CGRP+(antibody
staining) neurons in LPB. GFP/CGRP (%) = 14.5 ± 1.5; CGRP/GFP (%) = 63.2 ± 4.5; n = 7
sections from two injection experiments. Values are means ± s.e.m.. n.s., not significant; * p
< 0.05, ** p < 0.01, *** p < 0.001.
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Figure 7. Local CEA inhibitory circuits mediate feeding inhibition by PKC-δ+ neurons
a. Schematic illustrating combined in vivo light and drug delivery to CEA. b, IPSC of PKC-
δ− neurons by optogenetic activation of PKC-δ+ neurons is blocked by bicuculline. c, Food
intake in 24 h fasted animals photostimulated and infused with ACSF or 0.2 mM
bicuculline. n = 7 mice in each group. Two-way ANOVA (F(1, 12) = 0.869, p = 0.37) with
post-hoc Bonferroni t-test indicated that ChR2 induced feeding inhibition is blocked by
bicuculline. d. CEl PKC-δ−, but not PKC-δ+, neurons are silenced following CEl injection of
Cre-out rAAV-eNpHR3.0 (schematic). e. Silencing of CEl PKC-δ− neurons reduces food
intake in 24 h fasted animals. n = 9 mice in each group. Paired t-test, t(16) = 3.46, p =
0.0030. See Methods and Supplementary Fig. 9 for additional details. f-h. Food intake in 24
h fasted (g) or fed (h) animals after activation of PKC-δ− neurons (f). n = 10 (control) and 9
(activation) animals. Unpaired t-test, t(17) = 0.458, p = 0.65 (g); t(17) = 0.39, p = 0.70 (h).
Box plots show mean (+), median, quartiles (boxes), and range (whiskers). i. Food intake in
24 h fasted animals treated with CCK while activating CEl PKC-δ− neurons using Cre-out
ChR2. Unpaired t-test, t(17) = 2.64, p = 0.0093 (saline + activation vs. CCK + activation);
t(15) = 2.78, p = 0.014 (CCK + control vs. CCK + activation). Values are means ± s.e.m..
n.s., not significant; *p < 0.05; ** p < 0.01; *** p < 0.001.
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